Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Organon & Co. (NY: OGN )

30.41 +0.10 (+0.33%)
Official Closing Price Updated: 4:05 PM EST, Feb 2, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,227,593
Open 30.30
Bid (Size) 30.38 (1)
Ask (Size) 31.00 (2)
Prev. Close 30.31
Today's Range 30.14 - 30.50
52wk Range 22.88 - 39.48
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
AbbVie's Two-Decade Humira Monopoly Ends With Amgen's 55% Discounted Knockoff
Amgen launched its biosimilar knockoff on Tuesday at a steep discount. 
Via Investor's Business Daily
'It's The Only China Stock I'd Buy': Cramer On This E-Commerce Stock
On CNBC’s "Mad Money Lightning Round," Jim Cramer said Alibaba Group Holding Limited (NYSE: BABA) is the only China stock he would buy. 
Via Benzinga

Performance

YTD
+8.34%
+8.34%
1 Month
+8.34%
+8.34%
3 Month
+17.28%
+17.28%
6 Month
-6.63%
-6.63%
1 Year
-7.82%
-7.82%

More News

Read More
Organon Stock Scores Market Leadership With Jump To 83 RS Rating
Via Investor's Business Daily
Organon Makes Strategic Investment in Claria Medical to Support Development of Investigational Medical Device for Minimally Invasive Hysterectomy
From Organon & Co.
Via Business Wire
Organon To Present at the 41st Annual J.P. Morgan Healthcare Conference
From Organon & Co.
Via Business Wire
Organon Reports Better Than Expected Q3 Earnings
Via Benzinga
Organon Appoints Kirke Weaver as General Counsel and Corporate Secretary
From Organon & Co.
Via Business Wire
3 Dow Stocks to Take Seriously in 2023
Via InvestorPlace
'FTX Users May Seek DeFi Alternatives,' Interview With Origin Protocol's Andra Nicolau
Via Benzinga
Organon To Present at the Piper Sandler 34th Annual Healthcare Conference
From Organon & Co.
Via Business Wire
10 Spin-Off Stocks That Pay Dividends
Via Talk Markets
Recap: Organon Q3 Earnings
Via Benzinga
Organon Reports Results for the Third Quarter Ended September 30, 2022
From Organon & Co.
Via Business Wire
Looking Into Organon's Recent Short Interest
Via Benzinga
Origin Protocol Building DeFi & NFTs In The Bear: Interview With Co-Founder Joshua Fraser
Via Benzinga
Organon To Report Third Quarter Results and Host Conference Call on November 3, 2022
From Organon & Co.
Via Business Wire
Beat the Dow Jones With This Unstoppable Dividend Stock
Via The Motley Fool
Roofstock onChain Sells 1st Real Estate Property On Ethereum, Powered by Origin Protocol NFTs and Teller DeFi
Via Benzinga
Jim Cramer Says People Are Betting Against Stock Up 84% This Year: It Could Be An 'Up Big, Down Big Situation'
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For October 14, 2022
Via Benzinga
121 Stocks That Hit Their 52-Week Low
Via Benzinga
Netflix To Gain Around 8%? Plus This Analyst Slashes PT On Five9 By About 50%
Via Benzinga
No Need To Call A Broker: Real Estate NFTs Let Homeowners Cut Out The Middleman Via Roofstock and Origin Protocol
Via Benzinga
How Is The Market Feeling About Organon?
Via Benzinga
After FDA Regulatory Setback, Penny Stock ObsEva Cuts 70% Of Its Staff
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.